Showing 1 - 3 results of 3 for search 'John Mascarenhas', query time: 0.01s Refine Results
  1. 1
    Fedratinib in 2025 and beyond: indications and future applications

    Fedratinib in 2025 and beyond: indications and future applications by Alexander Coltoff, John Mascarenhas

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Single agent bevacizumab for myelofibrosis: results of the Myeloproliferative Disorders Research Consortium Trial

    Single agent bevacizumab for myelofibrosis: results of the Myeloproliferative Disorders Research Consortium Trial by Ruben A. Mesa, Richard T. Silver, Srdan Verstovsek, John Mascarenhas, Craig M. Kessler, Damiano Rondelli, Judy D. Goldberg, Roberto Marchioli, Erin P. Demakos, Lewis R. Silverman, Ronald Hoffman

    Published 2013-06-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Longitudinal graphics of patient-reported physical function in patients treated for hematologic malignancies

    Longitudinal graphics of patient-reported physical function in patients treated for hematologic malignancies by Gita Thanarajasingam, Vishal Bhatnagar, Brie N. Noble, Ting-Yu Chen, Mallorie H. Fiero, Ron Hoffman, Molly Jeffery, Gina L. Mazza, John Mascarenhas, Ruben Mesa, Meena Murugappan, Joseph Ross, Surbhi Sidana, Rahma Warsame, Paul G. Kluetz, Amylou C. Dueck

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: